AAVantgarde Bio receives FDA fast track designation for AAVB-039 in stargardt disease
The therapy delivers the full-length ABCA4 protein and has the potential to benefit all patients with ABCA4 mutations
The therapy delivers the full-length ABCA4 protein and has the potential to benefit all patients with ABCA4 mutations
Marksans Pharma gets USFDA nod for acid reflux drug
Glenmark USA is named in multiple antitrust and consumer protection lawsuits, including class actions, consolidated in the Eastern District of Pennsylvania, U.S
Glucagon is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
Subscribe To Our Newsletter & Stay Updated